Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Osteosarcoma
Drug:
doxorubicin hydrochloride
(
Topoisomerase II inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
FDA
Excerpt:
Doxorubicin Hydrochloride Injection/for Injection is an anthracycline topoisomerase inhibitor indicated…for the treatment of:…metastatic soft tissue sarcoma, metastatic bone sarcomas…
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.